NovaBiotics antifungal drug Novexatin receives patents
With this patents grant Novexatin, currently in phase 2b-ready clinical trial stage, moves closer to further clinical development and commercialisation. NovaBiotics’ granted and pending IP not only protects
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.